The North Carolina Translational and Clinical Sciences (NC TraCS) Institute wants you to be aware of a “Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)”...

Are you conducting human subjects research that involves direct interaction with participants? You will now be required to list your study on Research for Me @UNC. During your next IRB modification or renewal, you will be prompted...

The North Carolina Translational and Clinical Sciences (NC TraCS) Institute wants you to be aware of a “Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019...

Wake Forest Primate Signature Program provides access to nonhuman primates (NHPs) and related resources for studies that advance translational research. To assist new NHP researchers, the Program is providing funds for feasibility...

The NC TraCS Institute is pleased to announce awardees for $5K-50K matched pilot grants and $2K pilot grants related to the COVID-19 pandemic that were advanced for expedited review from the current cycle of proposals under...

The NC TraCS Institute is pleased to announce awardees for 2 programs: The 125th cycle of TraCS $2K pilot grants The 24th cycle of TraCS $2K Stakeholder Engagement vouchers In total, 10 applications were received...

As necessary, PCORI is adjusting the deadlines related to their funding announcements and quickly exploring ways that they can contribute to the evidence base for addressing this public health crisis. PCORI is working to...

Effective March 13th, 2020 In light of recent State of North Carolina and University statements on COVID-19 and the rapidly evolving outbreak, UNC-Chapel Hill is issuing a temporary policy related to human subjects-related...

HPDP is accepting applications for one-year planning grants of up to $3,000 to help UNC faculty conduct pilot projects in health promotion/disease prevention research using a community engagement approach. UNC faculty who currently...

Patients with inflammatory bowel disease (IBD) are frequently treated with immune suppression therapy. Do they face special risks associated with COVID-19? UNC Pediatric gastroenterologist Michael Kappelman, MD, MPH,...